Health Care/Hospital

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ...

2026-01-12 05:15 4213

From Clinical Recovery to Lifelong Empowerment: RoboCT Showcases Integrated Ecosystem Strategy at CES 2026

Leveraging Medical Robotics Heritage, the Company Expands into Consumer Market, Envisioning Exoskeletons as Integral 'New Organs' LAS VEGAS, Jan. 9, 2026 /PRNewswire/ -- At CES 2026, RoboCT is presenting a comprehensive vision that extends far beyond single products. The Chinese exoskeleton lead...

2026-01-10 04:00 412

Nona Biosciences Enters into Collaboration Agreement with Link Cell Therapies to Advance CAR-T Cell Therapies

CAMBRIDGE, Mass., Jan. 9, 2026 /PRNewswire/ -- Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery through innovative technology platforms, today announced that it has entered into a multi-target antibody discovery collaboration with Link Cell Therapies. This c...

2026-01-09 20:00 1754

Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology

CASTRES, France and PARIS, Jan. 9, 2026 /PRNewswire/ -- Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, today announced an integrated drug discovery collaboration to identify and develop novel small-molecule drug candidates in ...

2026-01-09 15:00 5821

Ribo Life Science (06938.HK) Successfully Lists on the Main Board of the Hong Kong Stock Exchange

HONG KONG, Jan. 9, 2026 /PRNewswire/ -- Ribo Life Science Co., Ltd. ("Ribo" or the "Company", stock code: 06938.HK), a leading company in small interfering RNA (siRNA) therapeutics, today successfully listed on the Main Board of Hong Kong Stock Exchange, marking a significant milestone in the cap...

2026-01-09 13:07 9325

Yuwell Medical Makes Its Debut at CES 2026: AI Expands the Boundaries of Health Management

LAS VEGAS, Jan. 9, 2026 /PRNewswire/ -- From January 6 to 9, CES 2026, held in Las Vegas—brought together 4,112 leading enterprises from around the world. As a leading Chinese medical device company, Yuwell Medical made its debut at CES.

2026-01-09 12:55 6446

Professor Wong Tin Chee Honored as GQ Hong Kong's Local Hero 2025 Giving Back to Society with TCM Wisdom Launches "The Pain Management CEO" Video Series Sharing the Path to Self-Management of Pain Conditions

HONG KONG, Jan. 9, 2026 /PRNewswire/ -- Wong Tin-Chee, Founder of Herbalgy Pharmaceutical Ltd. and Professor of Traditional Chinese Medicine, has been honored as one of the Local Heroes in GQ Hong Kong's Men of the Year 2025, in recognition of his long-standing commitment to advancing pain manage...

2026-01-09 10:00 5241

Innovent's Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo®) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration

SAN FRANCISCO and SUZHOU, China, Jan. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...

2026-01-09 08:00 1588

MediLink Has Signed an Additional Exclusive Licensing Agreement with Roche

SUZHOU, China, Jan. 8, 2026  /PRNewswire/ -- MediLink Therapeutics ("MediLink") today announced that it has entered into a new collaboration and exclusive licensing agreement with Roche (SIX: RO, ROG; OTCQX: RHHBY) for the development and commercialization of YL201, an investigational novel antib...

2026-01-09 08:00 1129

Kazia Therapeutics to Participate in J.P. Morgan Healthcare Conference Week; Clinical and Translational Update Anticipated Before Month-End

SYDNEY, Jan. 8, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA) today announced that its Chief Executive Officer,John Friend, MD, will be in San Francisco next week to participate in meetings during the annual J.P. Morgan Healthcare Conference week (JPM Week). During the week, Kazia will ...

2026-01-08 22:00 1359

IMG Opens Applications for 2026 Spring Semester 'Student Journey Scholarship'

INDIANAPOLIS, Jan. 8, 2026 /PRNewswire/ -- IMG (International Medical Group) is now accepting applications for itsStudent Journey Scholarship

2026-01-08 22:00 5316

Future FinTech Signs Framework Agreement to Acquire TransGen SC Tech Limited Expanding into the Biomedical R&D Sector

NEW YORK, Jan. 8, 2026 /PRNewswire/ -- Future FinTech a leading comprehensive financial and digital technology service provider, announced today that on January 7, 2026, its wholly-owned subsidiary, Future FinTech (Hong Kong) Limited ("FTFT HK"), signed a Framework Agreement (the "Agreement"), tha...

2026-01-08 21:15 2043

Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference

MELBOURNE, Australia and INDIANAPOLIS, Jan. 8, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the 44th Annual J.P. Morgan Healthcare Conference being held in Sa...

2026-01-08 19:00 7936

From Quantified Meditation to Bio-Computing, All Here Launches the Bio-Intelligence Initiative

GENEVA, Jan. 8, 2026 /PRNewswire/ -- All Here announces the launch of the Bio-Intelligence Initiative, the world's first research program exploring how deep meditative states of stability and silence of Mind give rise to measurable neural patterns, and how these complex neural signatures may insp...

2026-01-08 18:48 6704

Ark Biopharmaceutical Receives China Marketing Authorization for Aizhida for the Treatment of ADHD

SHANGHAI, Jan. 8, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced thatChina's National Medical Products Administration (NMPA) has approved the New Drug Application for Serdexmethylphenidate Chloride and Dexmethylphenidate Hydrochloride Capsules (Aizhida) f...

2026-01-08 17:58 5334

Cigna Healthcare Hong Kong Launches Critical Illness Plan to Enhance Health and Financial Protection for Customers

Comprehensive coverage for every stage of the health journey, plus a welcome offer supporting mental health HONG KONG, Jan. 8, 2026 /PRNewswire/ -- Cigna Healthcare Hong Kong today announced the launch of theCigna Healthcare VitalGuard Critical Illness PlanTM (the "Plan"), expanding its medical ...

2026-01-08 17:13 6223

Chinese Medical AI Team's MedGPT Tops Global Rankings in New Clinical Benchmark Published by Nature Portfolio Journal

BEIJING, Jan. 8, 2026 /PRNewswire/ -- A research team from China has introduced the first standardized framework for evaluating the clinical applicability of medical AI systems, with their findings published in npj Digital Medicine, a leading journal in the Nature Portfolio ranked in the top tier...

2026-01-08 14:51 2167

Beyond Wearables: Dreame Unveils Your AI-Driven Proactive Health Ecosystem at CES 2026

Dreame Redefines Wearable Technology at CES 2026 with Full-Scenario Health Ecosystem LAS VEGAS, Jan. 8, 2026 /PRNewswire/ -- Dreame Technology , a global leader in high-end consumer electronics and intelligent manufacturing, made its stunning global debut at the ...

2026-01-08 14:38 2375

LumiMind To Showcase Groundbreaking Non-Invasive BCI Technology With Live Gameplay Demo at CES 2026

LAS VEGAS, Jan. 7, 2026 /PRNewswire/ -- LumiMind, a next-generation neurotechnology company pioneering non-invasive, real-time neural modulation, will showcase breakthrough brain–computer interface (BCI) technology atCES 2026 inLas Vegas, including a live, real-time gameplay demonstration develop...

2026-01-08 13:51 133

Stay Fit, Stay Well -- The Fitness Industry Is Surging Worldwide

TaiSPO 2026 Pre-registration is Open TAIPEI, Jan. 8, 2026 /PRNewswire/ -- TaiSPO, Taiwan's Sports and Fitness Exhibition, will take place from March 25–28 at Taipei Nangang Exhibition Center Hall 2. Continuing the spirit of "Stay Fit, Stay Well," the event brings key players from the sports, fit...

2026-01-08 12:39 6193
1 ... 14151617181920 ... 858